Login / Signup

Ten-year real-world outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration using pro re nata regimen.

Pekko HujanenHeikki RuhaEemil LehtonenInka PirinenHeini HuhtalaAnu VaajanenUlla SyvänenAnja TuulonenHannele Uusitalo-Järvinen
Published in: BMJ open ophthalmology (2023)
VA was maintained short-term and long-term with anti-VEGF therapy using PRN treatment regimen.
Keyphrases
  • age related macular degeneration
  • growth factor
  • endothelial cells
  • vascular endothelial growth factor
  • metabolic syndrome
  • mesenchymal stem cells
  • glycemic control